Orna Therapeutics
Akinola Emmanuel is a Principal Scientist at Orna Therapeutics, with previous experience as a Scientist at Sana Biotechnology and Cobalt Biomedicine. They have a Ph.D in Immunology from the University of Chicago, where they were a Graduate Student from 2011 to 2018. Prior to that, they worked as a Laboratory Technician at Rutgers University, focusing on investigating genomic integrity. Akinola obtained a B.A in Genetics/Sociology from Rutgers University in 2009.
This person is not in the org chart
Orna Therapeutics
1 followers
Orna Therapeutics is a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA (oRNA) therapeutics with the potential to change the way it treats disease. Orna’s proprietary platform combines novel technology to create oRNAs that drive protein expression with validated and unique delivery solutions.